Cargando…

Individualized prognostic signature for pancreatic carcinoma validated by integrating immune-related gene pairs (IRGPs)

Increasingly attention is being given to immune molecules in pancreatic cancer. The purpose of this study was to understand the potential clinical application of immune-regulated genes (IRGs) in the stratification of prognosis and to facilitate the development of personalized prognostic information...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Yecheng, Yao, Pingan, Zhao, Kui, Ye, Zhenyu, Zhang, Haobo, Cao, Jianping, Zhang, Shuyu, Xing, Chungen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806356/ https://www.ncbi.nlm.nih.gov/pubmed/33393862 http://dx.doi.org/10.1080/21655979.2020.1860493

Ejemplares similares

A signature of immune-related gene pairs (IRGPs) for risk stratification and prognosis of oral cancer patients
por: Yu, Yanling, et al.
Publicado: (2022)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

The feedback loop of ANKHD1/lncRNA MALAT1/YAP1 strengthens the radioresistance of CRC by activating YAP1/AKT signaling
por: Yao, Ping-an, et al.
Publicado: (2022)

LncRNA FTX Contributes to the Progression of Colorectal Cancer Through Regulating miR-192-5p/EIF5A2 Axis
por: Zhao, Kui, et al.
Publicado: (2020)

miRNA: The nemesis of gastric cancer (Review)
por: XU, XIAOHUI, et al.
Publicado: (2013)

Gene pair based prognostic signature for colorectal colon cancer
por: Shu, Peng, et al.
Publicado: (2018)

Novel Immune Infiltrating Cell Signature Based on Cell Pair Algorithm Is a Prognostic Marker in Cancer
por: Zhang, Hao, et al.
Publicado: (2021)

Development and Validation of an Individualized Immune-Related Gene Pairs Prognostic Signature in Papillary Renal Cell Carcinoma
por: Zhou, Xianghong, et al.
Publicado: (2020)

B7-H3 promotes gastric cancer cell migration and invasion
por: Li, Yecheng, et al.
Publicado: (2017)

miR-31 affects colorectal cancer cells by inhibiting autophagy in cancer-associated fibroblasts
por: Yang, Xiaodong, et al.
Publicado: (2016)

Establishing and validating an ADCP-related prognostic signature in pancreatic ductal adenocarcinoma
por: Zhang, Deyu, et al.
Publicado: (2022)

Development and validation of a novel model incorporating MRI-based radiomics signature with clinical biomarkers for distinguishing pancreatic carcinoma from mass-forming chronic pancreatitis
por: Liu, Jingjing, et al.
Publicado: (2022)

Development and validation of an individual alternative splicing prognostic signature in gastric cancer
por: Lou, Shenghan, et al.
Publicado: (2021)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma
por: Tian, Xiong, et al.
Publicado: (2022)

An individualized immune prognostic signature in lung adenocarcinoma
por: Sun, Liangdong, et al.
Publicado: (2020)

Identification of an Autophagy-Related Pair Signature for Predicting Prognoses and Immune Activity in Pancreatic Adenocarcinoma
por: Zhang, Qian, et al.
Publicado: (2021)

Development and validation of an individualized diagnostic signature in thyroid cancer
por: Han, Li‐ou, et al.
Publicado: (2018)

Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma
por: Ni, Wenkai, et al.
Publicado: (2021)

Development and verification of an immune‐related gene pairs prognostic signature in ovarian cancer
por: Zhang, Bao, et al.
Publicado: (2021)

Development and validation of a hypoxia-related prognostic signature for breast cancer
por: Wang, Jianxin, et al.
Publicado: (2020)

Establishment and Validation of a Prognostic Immune Signature in Neuroblastoma
por: Yu, Yunhu, et al.
Publicado: (2021)

Identification and validation of an immune-related gene pairs signature for three urologic cancers
por: Xie, Biao, et al.
Publicado: (2022)

Systematic Analysis of an Invasion-Related 3-Gene Signature and Its Validation as a Prognostic Model for Pancreatic Cancer
por: Xu, Dafeng, et al.
Publicado: (2021)

Clinicopathological Analysis and Prognostic Assessment of Transcobalamin I (TCN1) in Patients with Colorectal Tumors
por: Zhu, Xinqiang, et al.
Publicado: (2020)

Development and validation of a novel ferroptosis‑related lncRNA prognostic signature for pancreatic adenocarcinoma
por: Li, Jian, et al.
Publicado: (2023)

Development and validation of a novel pseudogene pair-based prognostic signature for prediction of overall survival in patients with hepatocellular carcinoma
por: Du, Yajuan, et al.
Publicado: (2020)

Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma
por: Zhang, Xu, et al.
Publicado: (2021)

Integrated bioinformatics identifies the dysregulation induced by aberrant gene methylation in colorectal carcinoma
por: Ye, Zhenyu, et al.
Publicado: (2020)

Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer
por: Zhang, Qianshi, et al.
Publicado: (2021)

The PPARγ Agonist Rosiglitazone Enhances the Radiosensitivity of Human Pancreatic Cancer Cells
por: Wang, Zhenyu, et al.
Publicado: (2020)

Prognostic Implications of Immune-Related Gene Pairs Signatures in Bladder Cancer
por: Xiong, Hui, et al.
Publicado: (2021)

Identification and Validation of an Individualized Prognostic Signature of Bladder Cancer Based on Seven Immune Related Genes
por: Qiu, Huaide, et al.
Publicado: (2020)

Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma
por: Zhao, Jian-Gang, et al.
Publicado: (2023)

Identification and Validation of Immune- and Stemness-Related Prognostic Signature of Melanoma
por: Zhang, Yan, et al.
Publicado: (2021)

Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma
por: Kang, Chunmiao, et al.
Publicado: (2020)

Development of immune gene pair-based signature predictive of prognosis and immunotherapy in esophageal cancer
por: Cao, Kui, et al.
Publicado: (2021)

Hypoxia-Related Signature Is a Prognostic Biomarker of Pancreatic Cancer
por: Zhang, Jing-jing, et al.
Publicado: (2022)

Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2020)

Development and Validation of a 7-Gene Prognostic Signature to Improve Survival Prediction in Pancreatic Ductal Adenocarcinoma
por: Feng, Zengyu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_asbm2e41pc88r9g5kkvhpcmbjo